Happy May, everyone!
Noninvasive treatments are trending in the dental world—and investment firms are taking notice.
Curodont, the only commercially-available noninvasive peptide treatment for caries, recently received a significant investment from a billion-dollar asset management firm. This investment signals a shift toward non-invasive and biomimetic options—and shows that major firms see these products as drivers of growth.
Check out today's lead article to learn more.